Who should not take AOD-9604?
Documented caution flags for AOD-9604 include active malignancy and pregnancy / nursing. This is not exhaustive, and absence from this list is not a safety clearance. Anyone pregnant, nursing, or managing a serious medical condition should only consider it under a doctor's care, and safety data for AOD-9604 is limited.
Documented caution flags for AOD-9604
- Active malignancy
- Pregnancy / nursing
Reported side effects to weigh
- Mild injection-site irritation
- Rare: headache, fatigue
References
- Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone — Ng FM, Sun J, Sharma L, et al., Hormone Research, 2000
- The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice — Heffernan M, Summers RJ, Thorburn A, et al., Endocrinology, 2001
- Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans — Stier H, Vos E, Kenley D, Journal of Endocrinology and Metabolism, 2013;3(1-2):7-15
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on AOD-9604
Last updated 2026-06-15.